R2 Demographic data and its relation to clinical improvement in parkinsonian patients subjected to rTMS | ||||
| Minia Journal of Medical Research | ||||
| Articles in Press, Accepted Manuscript, Available Online from 06 August 2023 | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2023.226343.1485 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Baraah Hussien Soliman  1; W T Soliman2; Ahmed Elhussieny Ali3; Mohamed M Abdelkader 4
| ||||
| 1Neuropsychiatric department, faculty of medicine Minia university, Elminia, Egypt | ||||
| 2Neurology department, faculty of medicine, Minia university | ||||
| 3Neurology and psychiatery department, faculty of medicine minia university, Elminia, Egypt | ||||
| 4Neuropsychaitry department , faculty of medicine , minia university | ||||
| Abstract | ||||
| Introduction: Parkinsonism is a group of disorders characterized by bradykinesia, tremors, rigidity, postural instability and other non-motor manifestations. It includes many types, the most common among them is Parkinson's disease (PD) that affects about 9 million people worldwide. Treatment of parkinsonism can be divided into: Medical treatment which is considered the first line and surgical treatment. Transcranial magnetic stimulation (TMS) is a non-invasive safe device that causes stimulation of targeted brain cortical areas. It's used in many neuropsychiatric diseases including trails in parkinsonian disorders. Aim and Objectives: This study aims to investigate the relation between demographic data and clinical improvement after repetitive TMS. Patients and method: our study was held in Minia university hospital on 35 parkinsonian patients with specific inclusion criteria. They underwent 10 successive high frequency rTMS sessions and were assessed by Unified Parkinson's Disease Rating Scale (UPDRS). Results: Mean age of patients was 58.74 and male: female ratio: 24: 11. Four of them are diabetic, 15 are hypertensive, 7 complain of another disease. Four have positive family history. Thirty of them were on levodopa medication. Our study showed that there was no correlation between improvement in UPDRS resulted from TMS and demographic data except for levodopa use and UPDRS part II. Conclusion: Our study concluded that improvement appeared after TMS use, UPDRS score wasn't related to any of demographic data except what mentioned before. | ||||
| Keywords | ||||
| TMS; Parkinsonian disorders; repetitive TMS; Demographic data of parkinsonian patients | ||||
|
Statistics Article View: 101 |
||||
